- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05788874
Study of 18F-FAPI Applied to Gastrointestinal Cancer
April 12, 2023 updated by: First Affiliated Hospital Xi'an Jiaotong University
Comparative Study of 18F-FAPI and 18F-FDG PET/CT for Gastrointestinal Cancer
Comparison of tumor volume, number, and SUVmax of different primary foci (gastric, duodenal, and colon cancer), lymph node metastases (neck and supraclavicular, mediastinal, abdominal, and pelvic), and distant metastases (brain, lung, liver, bone, pleura, and peritoneum) detected by 18F-FAPI versus 18F-FDG PET/CT imaging.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yan Li
- Phone Number: 0086-15829364429
- Email: 29396779@qq.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
- Patients with high clinical suspicion of gastrointestinal tumor and negative 18F-FDG at first diagnosis
- Post-treatment patients with high clinical suspicion of recurrence or metastasis and negative 18F-FDG
Description
Inclusion Criteria:
- Patients with high clinical suspicion of gastrointestinal tumor and negative 18F-FDG at first diagnosis
- Post-treatment patients with high clinical suspicion of recurrence or metastasis and negative 18F-FDG
Exclusion Criteria:
- The diagnosis can be clarified by 18F-FDG PET/CT examination
- The presence of recurrence or metastasis can be clarified by 18F-FDG PET/CT examination
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
18F-FDG
|
18F-FAPI and 18F-FDG PET/CT for gastrointestinal cancer
|
18F-FAPI
|
18F-FAPI and 18F-FDG PET/CT for gastrointestinal cancer
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SUVmax
Time Frame: 1 day (During the inspection)
|
Measurement of the maximum standardized uptake value of the lesion
|
1 day (During the inspection)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
May 1, 2023
Primary Completion (Anticipated)
June 1, 2024
Study Completion (Anticipated)
December 1, 2024
Study Registration Dates
First Submitted
March 16, 2023
First Submitted That Met QC Criteria
March 28, 2023
First Posted (Actual)
March 29, 2023
Study Record Updates
Last Update Posted (Actual)
April 14, 2023
Last Update Submitted That Met QC Criteria
April 12, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- XJTU1AF-CRF-2022-021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Cancer
-
Five Prime Therapeutics, Inc.CompletedGastric Cancer | Gastrointestinal Cancer | Gastrointestinal Cancer MetastaticUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Dartmouth-Hitchcock Medical Center; West Virginia... and other collaboratorsActive, not recruitingGynecologic Cancer | Thoracic Cancer | Gastrointestinal Cancer | Other CancerUnited States
-
Royal Marsden NHS Foundation TrustMerck KGaA, Darmstadt, Germany; 4SC AGUnknownCancer | GI CancerUnited Kingdom
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UMC Utrecht; University of Cambridge; IRCCS Fondazione Stella MarisRecruitingGastrointestinal Cancer MetastaticNetherlands, United Kingdom, Italy
-
Bristol-Myers SquibbCompletedUpper Gastrointestinal CancerCanada
-
Sumitomo Pharma America, Inc.CompletedAdvanced Gastrointestinal CancerUnited States, Canada
-
University Medical Center GroningenCompleted
-
Goethe UniversityAgaplesion Markus Krankenhaus gGmbHCompletedAdvanced Gastrointestinal CancerGermany
-
Yonsei UniversitySmall and Medium Business AdministrationCompletedUpper Gastrointestinal CancerKorea, Republic of
-
Fudan UniversityNot yet recruitingOligometastatic Gastrointestinal CancerChina
Clinical Trials on 18F-FAPI and 18F-FDG PET/CT
-
Peking Union Medical College HospitalActive, not recruitingHepatocellular Carcinoma | Bile Duct CancerChina
-
Zhejiang UniversityCompletedPancreas Adenocarcinoma | Systemic Treatment | 18F-FAPI | Pathologic ResponseChina
-
Jinling Hospital, ChinaNot yet recruiting
-
Mara Veenstra, MDUMC Utrecht; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Not yet recruiting
-
SOFIERecruitingHepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Cholangiocarcinoma | Pancreatic Ductal Adenocarcinoma | Gastrointestinal CancersUnited States
-
Affiliated Cancer Hospital & Institute of Guangzhou...Not yet recruiting
-
The First Affiliated Hospital of Xiamen UniversityRecruitingGastric Cancer | Pancreatic Cancer | Liver CancerChina
-
Peking University Third HospitalRecruitingThyroid Eye DiseaseChina
-
The First Affiliated Hospital of Xiamen UniversityCompletedPositron-Emission Tomography | Tumor, SolidChina
-
The First Affiliated Hospital of Xiamen UniversityRecruitingPositron-Emission Tomography | FAP | SSTR2China